Details

NameSymbolSector
CHEMO PHARMA LABORATORIES LTD.CHEMOPHPharmaceuticals
Open
112
High
132
Low
112
Close
132
Volume
5196
Exchange
bse
Time
03-Oct-2025

Outlook

Score:  

3.25

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Chemo Pharma Laboratories is  
Long Body
Estimated Stoploss of Chemo Pharma Laboratories is ₹  
112
Chemo Pharma Laboratories has a  
Bullishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates the trend direction of Chemo Pharma Laboratories maybe  
Unpredictableℹ
, but keep a lookout for rise in price. 

Trend

Chemo Pharma Laboratories is in  
Sideways trendℹ
. 
Price of Chemo Pharma Laboratories is  
Upℹ
 by  

6.65

%. 
Target
Buy @ 

109.98

Sell @ 

140.94

Current @ 

132

Volume

The trades of Chemo Pharma Laboratories have been in  
Immenseℹ
 volume. 
The volume trades for Chemo Pharma Laboratories are  
Bullishℹ
 with  
Strong Buyersℹ
The trade volume of Chemo Pharma Laboratories is  

Up

 by  

559.78

% 

Valuation

The current market price of Chemo Pharma Laboratories is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 13cr and total assets worth ₹ 13cr, the balance sheet of Chemo Pharma Laboratories is:  
Balancedℹ
. 
Cashflow
Chemo Pharma Laboratories has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 10cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2025)

0% in operatingℹ
100% i.e. ₹ 10cr earned in investingℹ
0% in financingℹ
0% in otherℹ
Income
The income of Chemo Pharma Laboratories is  

₹ 0cr

 and  

Loss

 is :  

₹ 11cr

(*Jun 2025)

Chemo Pharma Laboratories Losses increased by:  

1100

% and Income is Up by:  

0

% 

(*Jun 2025)

The income of Chemo Pharma Laboratories is  

₹ 0cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Chemo Pharma Laboratories Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Mar 2025)

The income of Chemo Pharma Laboratories is  

₹ 0cr

 and  

Loss

 is :  

₹ 0cr

(*Dec 2024)

Chemo Pharma Laboratories Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.